The ratio of structural and functional status of myocardium to plasma level of stimulating growth factor expressed by gene 2 in patients with myocardial infarction without ST segment elevation


  • I.А. Mezhiievska National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Keywords: myocardial infarction without ST segment elevation, ST2, structural and functional state of the myocardium.

Abstract

Coronary heart disease remains one of the leading causes of temporary and persistent disability, invalidization and mortality in economically developed countries and is one of the most pressing problems in cardiology. Myocardial infarction is the most common manifestation of coronary heart disease and one of the main causes of the disability and mortality of the working population. The aim is to evaluate the structural and functional status of the myocardium in patients with acute myocardial infarction without ST segment elevation, depending on the plasma level of growth factor-stimulating factor expressed by gene 2 (ST2). 90 patients with acute myocardial infarction without ST segment elevation from 38 to 79 years old were examined. Among them, 60 (66.7%) male patients. Echocardiography assessed the structural and functional status of the myocardium. By enzyme-linked immunosorbent assay determined ST2 levels in blood plasma. It has been determined that myocardial infarction without ST segment elevation is associated with more severe structural left ventricular remodeling, left atrial overload, and decreased left ventricular contractility. In patients, myocardial infarction without ST segment elevation is associated with an increase in cases of left ventricular concentric hypertrophy. Analysis of the nature of diastolic transmitral blood flow showed a significant increase in cases of blood flow by type of pseudonormalization (43.5% versus 8.7%). Therefore, the data obtained showed that in patients with myocardial infarction without ST segment elevation, ST2 elevation was associated with a more frequent manifestation of diastolic transmitral blood flow by type of pseudonormalization. Patients with myocardial infarction without ST segment elevation showed a predominance of systolic dysfunction in the group with relatively high levels of ST2 in the blood plasma, and no significant differences in remodeling types were found in all study groups.

References

[1] Aimo, A., Vergaro, G., Ripoli, A., Bayes-Genis, A., Figal, D. A. P., de Boer, R. A., ... & Sabti, Z. (2017). Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure. JACC: Heart Failure, 5(4), 287-296. doi: 10.1016/j.jchf.2016.12.016

[2] Bayes-Genis, A., Nunez, J., & Lupon, J. (2017). Soluble ST2 for prognosis and monitoring in heart failure: the new gold standard?. Journal of the American College of Cardiology, (70), 2389-2392. doi: 10.1016/j.jacc.2017.09.031

[3] Bayes-Genis, A., Núñez, J., Núñez, E., Martínez, J. B., Ferrer, M. C. P., de Antonio, M., ... & Rosés, J. L. (2016). Multi-biomarker profiling and recurrent hospitalizations in heart failure. Frontiers in cardiovascular medicine, 3, 37. doi: 10.3389/fcvm.2016.00037

[4] Bønaa, K. H., & Steigen, T. (2017). Coronary angiography in non-ST-elevation acute myocardial infarction-whom and when? Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke, 137(22). doi: 10.4045/tidsskr.17.0492

[5] Gilutz, H., Shindel, S., & Shoham-Vardi, I. (2019). Adherence to NSTEMI Guidelines in the Emergency Department: Regression to Reality. Critical pathways in cardiology, 18(1), 40-46. doi: 10.1097/HPC.0000000000000165

[6] Güntekin, Ü., Tosun, V., Kilinç, A. Y., Saydam, G., Korucuk, N., & Bozdemir, M. N. (2018). ST segment elevation myocardial infarction (STEMI) patients are more likely to achieve lipid-lowering treatment goals: A retrospective analysis of patients presenting with first acute coronary syndromes. Medicine, 97(39). doi: 10.1097/MD.0000000000012225

[7] Handziuk, V. A. (2014). Analysis of incidence of coronary heart disease in Ukraine. Ukrainian Cardiology Journal, (3), 45-52.

[8] Harrington, D. H., Stueben, F., & Lenahan, C. M. (2019). ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction: Medical and Surgical Interventions. Critical care nursing clinics of North America, 31(1), 49-64. doi: 10.1016/j.cnc.2018.10.002

[9] Held, E. P., & Henry, T. D. (2018). When small vessels become big problems! Microvascular dysfunction in NSTEMI. Catheter CardiovascInterv, 92(6), 1075-1076. doi: 10.1002/ccd.27966

[10] Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., ... & Hindricks, G. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European heart journal, 39(2), 119-177. doi.org/10.1093/eurheartj/ehx393

[11] Januzzi, J. L., Mebazaa, A., & Di Somma, S. (2015). ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel. The American journal of cardiology, 115(7), 26B-31B. doi: 10.1016/j.amjcard.2015.01.037

[12] Kamińska, J., Koper, O. M., Siedlecka-Czykier, E., Matowicka-Karna, J., Bychowski, J., & Kemona, H. (2018). The utility of inflammation and platelet biomarkers in patients with acute coronary syndromes. Saudi Journal of Biological Sciences, 25(7), 1263-1271. doi: 10.1016/j.sjbs.2016.10.015

[13] Kokkoz, Ç., Bilge, A., Irik, M., Dayangaç, H. I., Hayran, M., Akarca, F. K., ... & Çavuş, M. (2018). Prognostic value of plasma ST2 in patients with non-ST segment elevation acute coronary syndrome. Turkish journal of emergency medicine, 18(2), 62-66. doi: 10.1016/j.tjem.2018.01.003

[14] Lax, A., Sanchez-Mas, J., Asensio-Lopez, M. C., Fernandez-Del Palacio, M. J., Caballero, L., Garrido, I. P., ... & Pascual-Figal, D. A. (2015). Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction. JACC: Heart Failure, 3(1), 50-58. doi: 10.1016/j.jchf.2014.07.015

[15] Lupón, J., Sanders-van Wijk, S., Januzzi, J. L., de Antonio, M., Gaggin, H. K., Pfisterer, M., ... & Bayes-Genis, A. (2016). Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study. International journal of cardiology, 204, 242-247. doi: 10.1016/j.ijcard.2015.11.163

[16] Manfredonia, L., Lanza, G. A., Crudo, F., Lamendola, P., Graziani, F., Villano, A., ... & Lombardo, A. (2019). Diagnostic role of echocardiography in patients admitted to the emergency room with suspect no-ST-segment elevation acute myocardial infarction. Eur Rev Med Pharmacol Sci, 23(2), 826-832. doi: 10.26355/eurrev_201901_16897

[17] Meeusen, J. W., Johnson, J. N., Gray, A., Wendt, P., Jefferies, J. L., Jaffe, A. S., ... & Saenger, A. K. (2015). Soluble ST2 and galectin-3 in pediatric patients without heart failure. Clinical biochemistry, 48(18), 1337-1340. doi: 10.1016/j.clinbiochem.2015.08.007

[18] Milleron, O., Bouleti, C., Mazouz, S., Brochet, E., Rouzet, F., Nataf, P., ... & Vahanian, A. (2017). Eclipsed mitral regurgitation: an unusual cause of acute heart failure. European Heart Journal-Cardiovascular Imaging, 18(10), 1163-1169. doi: 10.1093/ehjci/jew192

[19] Pascual-Figal, D. A., & Januzzi, J. L. (2015). The biology of ST2: the international ST2 consensus panel. The American journal of cardiology, 115(7), 3B-7B. doi: 10.1016/j.amjcard.2015.01.034

[20] Pascual-Figal, D. A., Pérez-Martínez, M. T., Asensio-Lopez, M. C., Sanchez-Más, J., García-García, M. E., Martinez, C. M., ... & Lax, A. (2018). Pulmonary production of soluble ST2 in heart failure. Circulation: Heart Failure, 11(12), e005488. doi: 10.1161/CIRCHEARTFAILURE.118.005488

[21] Puymirat, E., Bonaca, M., Fumery, M., Tea, V., Aissaoui, N., Lemesles, G., ... & Schiele, F. (2019). Atherothrombotic risk stratification after acute myocardial infarction: the Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French registry of acute ST elevation or non‐ST elevation myocardial infarction registries. Clinical cardiology, 42(2), 227-234. doi: 10.1002/clc.23131

[22] Rupprecht, H. J., Geeren, M., Weilemann, S., & Schuster, H. P. (2019). Acute coronary syndrome without ST-elevation (NSTE-ACS). Herz, 44(1), 10-15. doi: 10.1007/s00059-018-4776-1

[23] Tseng, C. C., Huibers, M. M., van Kuik, J., de Weger, R. A., Vink, A., & de Jonge, N. (2018). The interleukin-33/ST2 pathway is expressed in the failing human heart and associated with pro-fibrotic remodeling of the myocardium. Journal of cardiovascular translational research, 11(1), 15-21. doi: 10.1007/s12265-017-9775-8

[24] van Vark, L. C., Lesman-Leegte, I., Baart, S. J., Postmus, D., Pinto, Y. M., Orsel, J. G., ... & Hillege, H. L. (2017). Prognostic value of serial ST2 measurements in patients with acute heart failure. Journal of the American College of Cardiology, 70(19), 2378-2388. doi: 10.1016/j.jacc.2017.09.026
Published
2019-05-05
How to Cite
Mezhiievska, I. (2019). The ratio of structural and functional status of myocardium to plasma level of stimulating growth factor expressed by gene 2 in patients with myocardial infarction without ST segment elevation. Biomedical and Biosocial Anthropology, (35), 38-42. https://doi.org/https://doi.org/10.31393/bba35-2019-06